Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03434392 · ClinicalTrials.gov registry record · NA
QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing
A NA study of Chronic Pain and Chronic Pancreatitis, sponsored by Anna Evans Phillips.
- Recruiting
- Registry status
- NA
- Development phase
- 500
- Enrollment target
- 2
- Study locations
NCT03434392: Recruiting NA study of Chronic Pain and Chronic Pancreatitis, sponsored by Anna Evans Phillips.
NCT03434392 is a NA study of Chronic Pain and Chronic Pancreatitis that is actively recruiting participants, run by Anna Evans Phillips. The registered enrollment target is 500 participants, below the 771-participant average among 301 other Chronic Pain trials with a reported enrollment target (35% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03434392, a NA study of Chronic Pain and Chronic Pancreatitis, is actively recruiting participants, sponsored by Anna Evans Phillips.
- RECRUITING
- Registry status
- NA
- Development phase
- 500 participants
- Enrollment target
- 2
- Study locations
Study Summary
Quantitative Sensory Testing (QST) is a novel investigative technique used in other pain conditions to evaluate patterns of chronic pain, and in this study will be used to elucidate pain patterns in patients with Chronic Pancreatitis (CP). QST uses a specific series of standardized stimulations to map the pain system. QST has the potential to change and improve the treatment paradigm for patients with CP and may eventually be able to predict response to invasive CP therapies.
Primary Outcome
Assignment to one of four groups (Segmental Sensitization, Systemic Sensitization, Impaired Conditioned Pain Modulation, or Other) based on combination of patient-reported pain symptoms. Temporal summation pain symptoms are measured on visual analogue scales which are measured from 0 (minimum) to 10 (maximum). 10 on this scale indicates worse pain; 0 indicates no pain. Sensitization scores are measured via patient reported thresholds in kilopascals. Conditioned Pain modulation is measured also v
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Quantitative Sensory Test 1
- DIAGNOSTIC_TEST Quantitative Sensory Test 2
- DIAGNOSTIC_TEST Quantitative Sensory Test 3
Study Locations (2)
Maryland
- Johns Hopkins Medical Institutions - Baltimore
Pennsylvania
- University of Pittsburgh Medical Center - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2017-10-24 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT03434392 shows while recruiting
NCT03434392 is an interventional study that assigns participants to a tested intervention. The registered 500 participants enrollment target is mid-sized for trials with a published cap, below the 771-participant average among 301 other Chronic Pain trials with a reported enrollment target (35% lower).
The record links to 2 conditions, with Chronic Pain appearing as the primary indexed condition, and to 3 interventions - of which Quantitative Sensory Test 1 is the first listed.
NCT03434392 reports a single indexed study location in Maryland, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03434392 about?
NCT03434392 is a clinical study titled "QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing". Quantitative Sensory Testing (QST) is a novel investigative technique used in other pain conditions to evaluate patterns of chronic pain, and in this study will be used to elucidate pain patterns in patients with Chronic Pancreatitis (CP). QST uses a specific series of standardized stimulations to m...
What is the current status of trial NCT03434392?
This trial is currently recruiting. It is a NA study. The enrollment target is 500 participants. The study started on 2017-10-24. Estimated completion is 2026-06-30.
What conditions does trial NCT03434392 study?
This clinical trial studies the following conditions: Chronic Pain, Chronic Pancreatitis.
What interventions are being tested in trial NCT03434392?
The interventions under investigation include: Quantitative Sensory Test 1 (DIAGNOSTIC_TEST), Quantitative Sensory Test 2 (DIAGNOSTIC_TEST), Quantitative Sensory Test 3 (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03434392?
This trial is sponsored by Anna Evans Phillips, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03434392 being conducted?
This trial has 2 study locations across Maryland, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03434392's enrollment target sits among peer trials
500 18th of 301 higher than 280 of 301 other Chronic Pain trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software
RECRUITING · NA
-
Local Cerebral Oxygenation in Chronic Pain Patients Utilizing Spinal Cord Stimulation
RECRUITING · NA
-
Group Medical Visits and Chiropractic Care for Older Adults With Chronic Spine Pain
RECRUITING · NA
-
Emotional Awareness and Expression Therapy for People With Persistent Pain Following Orthopedic Trauma
RECRUITING · NA
-
Group-based Integrative Pain Management in Primary Care Safety Net Clinics
RECRUITING · NA
-
Opioid and Pain Treatment in Indigenous Communities (OPTIC) Trial
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00001230 · 500 participants
Host Response to Infection and Treatment in Filarial Diseases
- NCT00001529 · 500 participants
Improved Methods of Cell Selection for Bone Marrow Transplant Alternatives
- NCT00697411 · 500 participants
Study of Selected X-Linked Disorders: Aicardi Syndrome
- NCT00903110 · 500 participants
Global Patient Registry to Monitor Long-term Safety and Effectiveness of Increlex® in Children and Adolescents With Severe Primary Insulin-like Growth Factor-1 Deficiency (SPIGFD).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI